Citizen Petition from Siri & Glimstad LLP on behalf of Informed Consent Action Network
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Siri & Glimstad LLP on behalf of Informed Consent Action Network
- Posted
- Sep 25, 2025
- Comment period
- Sep 25, 2025 – ?
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Acetaminophen autism risk | Acetaminophen pregnancy warning labels | Informed consent and warnings | Neurodevelopmental effects of paracetamol | Precautionary principle |
|---|
10 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Nov 13, 2025Comment from chris white MDSupportIndividualRead comment →
- Nov 11, 2025Comment from AnonymousSupportIndividualRead comment →
- Oct 31, 2025Comment from AnonymousSupportIndividual📎 Attachment
The commenter, an autism parent, strongly supports the ICAN citizen petition and requests additional FDA label changes regarding the risks of acetaminophen use during labor, delivery, and early childhood. They argue that evidence links acetaminophen exposure to neurodevelopmental disorders like autism and urge the FDA to provide clear warnings to protect susceptible children.
Read comment → - Oct 29, 2025Comment from J ThurmanSupportIndividual
The commenter is an individual urging the FDA to revise the labeling of over-the-counter acetaminophen products to clearly warn about potential dangers to children. They argue that the FDA has lost public trust and should prioritize public safety over pharmaceutical interests.
Read comment → - Oct 7, 2025Comment from Amanda LoveSupportIndividualRead comment →
